Innoveren Scientific Inc.
IVRN
$0.0002
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 543.90K | 12.60K | 116.00K | -- | 36.70K |
| Total Receivables | 65.70K | 14.00K | 17.10K | 29.50K | 35.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 139.90K | 140.00K | 170.20K | 54.40K | 102.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 749.50K | 166.70K | 303.30K | 83.80K | 174.00K |
|
|
|||||
| Total Current Assets | 749.50K | 166.70K | 303.30K | 83.80K | 174.00K |
| Net Property, Plant & Equipment | 15.50K | 17.10K | 18.80K | 20.40K | 22.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 24.30K | 24.30K | 27.30K | 33.10K | 44.50K |
| Total Assets | 789.30K | 208.10K | 349.40K | 137.40K | 240.60K |
|
|
|||||
| Total Accounts Payable | 1.26M | 1.14M | 1.05M | 971.50K | 842.80K |
| Total Accrued Expenses | 2.31M | 2.28M | 2.05M | 1.94M | 1.66M |
| Short-term Debt | 4.32M | 4.34M | 5.66M | 3.76M | 3.75M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 123.20K | 135.20K | 160.70K | 167.80K | 167.30K |
| Total Finance Division Other Current Liabilities | 1.66M | 730.70K | 744.10K | 640.90K | 268.80K |
| Total Other Current Liabilities | 1.66M | 730.70K | 744.10K | 640.90K | 268.80K |
| Total Current Liabilities | 9.66M | 8.63M | 9.66M | 7.48M | 6.69M |
|
|
|||||
| Total Current Liabilities | 9.66M | 8.63M | 9.66M | 7.48M | 6.69M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 4.32M | 4.34M | 5.66M | 3.76M | 3.75M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.02M | 2.02M | 2.02M | 2.02M | 1.70M |
| Total Liabilities | 11.68M | 10.64M | 11.68M | 9.49M | 8.39M |
|
|
|||||
| Common Stock & APIC | 49.77M | 49.72M | 49.65M | 49.53M | 49.25M |
| Retained Earnings | -61.09M | -60.60M | -61.42M | -59.33M | -57.83M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -11.33M | -10.87M | -11.77M | -9.80M | -8.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 438.80K | 438.80K | 438.80K | 438.80K | 438.80K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 438.80K | 438.80K | 438.80K | 438.80K | 438.80K |
|
|
|||||
| Total Common Equity | -11.33M | -10.87M | -11.77M | -9.80M | -8.59M |
| Total Preferred Equity | 438.80K | 438.80K | 438.80K | 438.80K | 438.80K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.89M | -10.43M | -11.33M | -9.36M | -8.15M |
|
|
|||||